We are live on ! Find out more
ZURA icon

Zura Bio
ZURA

3 hedge funds and large institutions have $24.7K invested in Zura Bio in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.09% more ownership

Funds ownership: 0% → 0.09% (+0.09%)

92% less funds holding

Funds holding: 36 → 3 (-33)

94% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 35

100% less capital invested

Capital invested by funds: $89.9M → $24.7K (-$89.8M)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
3
Holders Change
-33
Holders Change %
-91.67%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
1
Closed
35
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SAMU
SONA Asset Management (US)
New York
+$299K
2
TRCT
Tower Research Capital (TRC)
New York
+$1.22K

Top Sellers

Rank Fund Capital Flow
1
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$13.3M
2
MF
Magnetar Financial
Illinois
-$11.8M
3
GCL
Glazer Capital LLC
New York
-$10.2M
4
Marshall Wace
Marshall Wace
United Kingdom
-$4.97M
5
SCM
Shaolin Capital Management
Florida
-$4.59M

ZURA Hedge Fund Activity: Q1 2023 in Review

3 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Zura Bio (ZURA) for Q1 2023, worth a combined $24.7K — down 100% from $89.9M a quarter earlier.

Sellers outnumbered buyers: 35 funds closed out of ZURA and 2 opened new positions — a net loss of 33 holders — while 1 trimmed existing stakes and 0 added.

The largest buyer was SONA Asset Management (US), opening a new position worth an estimated $299K. The largest seller was Hudson Bay Capital Management, exiting entirely with an estimated $13.3M sold.

  • 3 institutional investors held Zura Bio (ZURA) as of Q1 2023, down from 36 in Q4 2022.
  • Funds reported $24.7K of Zura Bio stock for Q1 2023, down 100% quarter-over-quarter.
  • 2 funds opened new Zura Bio positions in Q1 2023 and 35 closed out, a net change of -33 holders.
  • The largest Zura Bio buyer in Q1 2023 was SONA Asset Management (US), an estimated $299K added.
  • The largest Zura Bio seller in Q1 2023 was Hudson Bay Capital Management, an estimated $13.3M sold.

Based on aggregated 13F filings for Q1 2023.